329 related articles for article (PubMed ID: 16169620)
1. Implementation of two-step vaccination in the control of bovine viral diarrhoea (BVD).
Moennig V; Eicken K; Flebbe U; Frey HR; Grummer B; Haas L; Greiser-Wilke I; Liess B
Prev Vet Med; 2005 Nov; 72(1-2):109-14; discussion 215-9. PubMed ID: 16169620
[TBL] [Abstract][Full Text] [Related]
2. [Mental notes in tracking BVDV carriers].
Laureyns J; Ribbens S; de Kruif A
Tijdschr Diergeneeskd; 2006 May; 131(9):330-4. PubMed ID: 16711566
[TBL] [Abstract][Full Text] [Related]
3. Fetal protection against continual exposure to bovine viral diarrhea virus following administration of a vaccine containing an inactivated bovine viral diarrhea virus fraction to cattle.
Grooms DL; Bolin SR; Coe PH; Borges RJ; Coutu CE
Am J Vet Res; 2007 Dec; 68(12):1417-22. PubMed ID: 18052749
[TBL] [Abstract][Full Text] [Related]
4. [Perspectives on BVD eradication in Germany].
Moennig V; Greiser-Wilke I
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):222-6. PubMed ID: 12784556
[TBL] [Abstract][Full Text] [Related]
5. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine.
Cortese VS; Grooms DL; Ellis J; Bolin SR; Ridpath JF; Brock KV
Am J Vet Res; 1998 Nov; 59(11):1409-13. PubMed ID: 9829398
[TBL] [Abstract][Full Text] [Related]
6. Genetic characterization of bovine viral diarrhea viruses isolated from persistently infected calves born to dams vaccinated against bovine viral diarrhea virus before breeding.
Bolin SR; Lim A; Grotelueschen DM; McBeth WW; Cortese VS
Am J Vet Res; 2009 Jan; 70(1):86-91. PubMed ID: 19119952
[TBL] [Abstract][Full Text] [Related]
7. Effects of exposure to calves persistently infected with bovine viral diarrhea virus type 1b and subsequent infection with Mannheima haemolytica on clinical signs and immune variables: model for bovine respiratory disease via viral and bacterial interaction.
Burciaga-Robles LO; Step DL; Krehbiel CR; Holland BP; Richards CJ; Montelongo MA; Confer AW; Fulton RW
J Anim Sci; 2010 Jun; 88(6):2166-78. PubMed ID: 20154164
[TBL] [Abstract][Full Text] [Related]
8. Response of cattle persistently infected with noncytopathic bovine viral diarrhea virus to vaccination for bovine viral diarrhea and to subsequent challenge exposure with cytopathic bovine viral diarrhea virus.
Bolin SR; McClurkin AW; Cutlip RC; Coria MF
Am J Vet Res; 1985 Dec; 46(12):2467-70. PubMed ID: 3002214
[TBL] [Abstract][Full Text] [Related]
9. Control of BVDV-infection on common grassland--the key for successful BVDV-eradication in Lower Austria.
Rossmanith W; Janacek R; Wilhelm E
Prev Vet Med; 2005 Nov; 72(1-2):133-7; discussion 215-9. PubMed ID: 16213041
[TBL] [Abstract][Full Text] [Related]
10. [BVD approach: vaccination and eradication].
Verberne LR
Tijdschr Diergeneeskd; 2000 Apr; 125(7):218-21. PubMed ID: 10775986
[TBL] [Abstract][Full Text] [Related]
11. [Vaccines against infection with bovine viral diarrhea virus/mucosal disease (BVDV/MD): a short overview].
Beer M; Wolf G
Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):252-8. PubMed ID: 12784561
[TBL] [Abstract][Full Text] [Related]
12. Effects of modified-live bovine viral diarrhea virus vaccines containing either type 1 or types 1 and 2 BVDV on heifers and their offspring after challenge with noncytopathic type 2 BVDV during gestation.
Ficken MD; Ellsworth MA; Tucker CM; Cortese VS
J Am Vet Med Assoc; 2006 May; 228(10):1559-64. PubMed ID: 16677126
[TBL] [Abstract][Full Text] [Related]
13. BVDV control and eradication in Europe--an update.
Ståhl K; Alenius S
Jpn J Vet Res; 2012 Feb; 60 Suppl():S31-9. PubMed ID: 22458198
[TBL] [Abstract][Full Text] [Related]
14. The control of bovine viral diarrhoea virus in Europe: today and in the future.
Lindberg A; Brownlie J; Gunn GJ; Houe H; Moennig V; Saatkamp HW; Sandvik T; Valle PS
Rev Sci Tech; 2006 Dec; 25(3):961-79. PubMed ID: 17361763
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and control of BVD in the U.S.
Van Campen H
Vet Microbiol; 2010 Apr; 142(1-2):94-8. PubMed ID: 19833455
[TBL] [Abstract][Full Text] [Related]
16. [Clinical-virologic course after superinfection of persistently infected cattle with cytopathogenic bovine viral diarrhea virus strains].
Loehr BI; Frey HR; Moennig V; Greiser-Wilke I
Dtsch Tierarztl Wochenschr; 1998 May; 105(5):201-4. PubMed ID: 9646556
[TBL] [Abstract][Full Text] [Related]
17. Simulation study to assess the efficiency of a test-and-cull scheme to control the spread of the bovine viral-diarrhoea virus in a dairy herd.
Viet AF; Fourichon C; Seegers H
Prev Vet Med; 2006 Oct; 76(3-4):151-66. PubMed ID: 16774794
[TBL] [Abstract][Full Text] [Related]
18. Fetal protection following exposure to calves persistently infected with bovine viral diarrhea virus type 2 sixteen months after primary vaccination of the dams.
Ellsworth MA; Fairbanks KK; Behan S; Jackson JA; Goodyear M; Oien NL; Meinert TR; Leyh RD
Vet Ther; 2006; 7(3):295-304. PubMed ID: 17039452
[TBL] [Abstract][Full Text] [Related]
19. [Control of bovine viral diarrhea/mucosal disease in the district of Kamenz on a voluntary basis--ways, successes, limitations].
Brützke A; Donat K; Truyen U
Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):48-57. PubMed ID: 21309165
[TBL] [Abstract][Full Text] [Related]
20. Prevention of transplacental infection of bovine foetus by bovine viral diarrhoea virus through vaccination.
Patel JR; Shilleto RW; Williams J; Alexander DC
Arch Virol; 2002 Dec; 147(12):2453-63. PubMed ID: 12491111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
